Patheon Inc 2100 Syntex Court Mississauga,
ON L5N 7K9 Canada - Map Phone: 905-812-2125 Fax: 905-812-6705 Website: http://www.patheon.com
| Index Membership: | N/A | | Sector: | Healthcare | | Industry: | Medical Laboratories & Research | | Full Time Employees: | 4,700 |
|
Patheon Inc. provides drug development and manufacturing services to the pharmaceutical, biotechnology, and specialty pharmaceutical companies worldwide. It primarily offers commercial manufacturing outsourcing services and outsourced pharmaceutical development services. The companys commercial manufacturing outsourcing services include the activities primarily relating to various sterile dosage forms, as well as solid, conventional, and specialized dosage forms. It also develops a range of specialized capabilities in high potency, controlled substances, and sustained release products. Its pharmaceutical development services comprise early development; pre-formulation, formulation, and development of dosage forms; manufacturing of development stage products during the regulatory drug approval process, including the manufacture of pilot batches; scale-up and technology transfer services designed to validate commercial-scale drug manufacturing processes; and development of analytical methods and delivery of analytical services. Patheon Inc. was founded in 1974 and is based in Mississauga, Canada. Key Statistics
| |
| | Pay | Exercised | Mr. James C. Mullen ,
54 Chief Exec. Officer and Director | 1.96M | 0.00 | Mr. Stuart R. Grant ,
57 Chief Financial Officer and Exec. VP | 522.00k | 0.00 | Mr. Michael E. Lytton J.D.,
55 Exec. VP of Corp. Devel. & Strategy and Gen. Counsel | 627.00k | 0.00 | Ms. Antonella Mancuso ,
47 Chief Manufacturing Officer and Pres of Global Commercial Operations | 791.00k | 0.00 | Mr. Geoffrey M. Glass ,
39 Pres of Product and Technology Commercialization | 570.00k | 0.00 |
|
| | Amounts are as of 2012-12-30 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year. | | Currency in CAD. |
|